10x Genomics, Inc. · NASDAQ:TXG
Saxonov Serge sold 10,486 10x Genomics, Inc. shares (Form 4)
Traded Aug 26, 2026 · Filed Aug 28, 2026
On Aug 26, 2026, Saxonov Serge (Director, Chief Executive Officer) sold 10,486 10x Genomics, Inc. shares at an average US$63.70 for US$668K under a trading plan, leaving 1,075,349 shares. Filed Aug 28, 2026 (Form 4).
- Sold
- 10,486 shares
- Price
- US$63.70 average (US$63.02 to US$64.75)
- Value
- US$668K
- Holding after
- 1,075,349 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Class A Common Stock | Sale | 3,500 | US$63.02 | 1,082,335 | Direct |
| Aug 26, 2026 | Class A Common Stock | Sale | 6,494 | US$63.98 | 1,075,841 | Direct |
| Aug 26, 2026 | Class A Common Stock | Sale | 492 | US$64.75 | 1,075,349 | Direct |
Source
Related
- 10x Genomics, Inc.
- Saxonov Serge
- 10x Genomics, Inc. shareholders
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 3, 2026
- Form 4 · Saxonov Serge · Aug 26, 2026
- Form 4 · Saxonov Serge · Aug 24, 2026
- Form 4 · Saxonov Serge · Jun 24, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026